Correlation Between BB Biotech and Lyxor MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Lyxor MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Lyxor MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Lyxor MSCI China, you can compare the effects of market volatilities on BB Biotech and Lyxor MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Lyxor MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Lyxor MSCI.

Diversification Opportunities for BB Biotech and Lyxor MSCI

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between BION and Lyxor is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Lyxor MSCI China in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyxor MSCI China and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Lyxor MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyxor MSCI China has no effect on the direction of BB Biotech i.e., BB Biotech and Lyxor MSCI go up and down completely randomly.

Pair Corralation between BB Biotech and Lyxor MSCI

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Lyxor MSCI. But the stock apears to be less risky and, when comparing its historical volatility, BB Biotech AG is 1.21 times less risky than Lyxor MSCI. The stock trades about -0.04 of its potential returns per unit of risk. The Lyxor MSCI China is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,527  in Lyxor MSCI China on September 20, 2024 and sell it today you would earn a total of  34.00  from holding Lyxor MSCI China or generate 2.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  Lyxor MSCI China

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Lyxor MSCI China 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor MSCI China are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Lyxor MSCI showed solid returns over the last few months and may actually be approaching a breakup point.

BB Biotech and Lyxor MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Lyxor MSCI

The main advantage of trading using opposite BB Biotech and Lyxor MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Lyxor MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyxor MSCI will offset losses from the drop in Lyxor MSCI's long position.
The idea behind BB Biotech AG and Lyxor MSCI China pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios